These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
40 related articles for article (PubMed ID: 16503641)
1. Identification of Oleanolic Acid as Allosteric Agonist of Integrin α Jin L; Han X; Zhang X; Zhao Z; Ulrich J; Syrovets T; Simmet T Front Pharmacol; 2021; 12():702529. PubMed ID: 34603018 [TBL] [Abstract][Full Text] [Related]
2. The Promiscuous Profile of Complement Receptor 3 in Ligand Binding, Immune Modulation, and Pathophysiology. Lamers C; Plüss CJ; Ricklin D Front Immunol; 2021; 12():662164. PubMed ID: 33995387 [TBL] [Abstract][Full Text] [Related]
3. Can Integrin Agonists Have Cards to Play against Cancer? A Literature Survey of Small Molecules Integrin Activators. Tolomelli A; Galletti P; Baiula M; Giacomini D Cancers (Basel); 2017 Jul; 9(7):. PubMed ID: 28678151 [TBL] [Abstract][Full Text] [Related]
4. In vivo targeting of activated leukocytes by a β2-integrin binding peptide. Ranta TM; Suojanen J; Peñate-Medina O; Will O; Tower RJ; Glüer C; Kairemo K; Gahmberg CG; Koivunen E; Sorsa T; Saris PE; Reunanen J Mol Diagn Ther; 2014 Feb; 18(1):39-44. PubMed ID: 23982749 [TBL] [Abstract][Full Text] [Related]
5. Small molecule agonist of very late antigen-4 (VLA-4) integrin induces progenitor cell adhesion. Vanderslice P; Biediger RJ; Woodside DG; Brown WS; Khounlo S; Warier ND; Gundlach CW; Caivano AR; Bornmann WG; Maxwell DS; McIntyre BW; Willerson JT; Dixon RA J Biol Chem; 2013 Jul; 288(27):19414-28. PubMed ID: 23703610 [TBL] [Abstract][Full Text] [Related]
11. A simple, no-wash cell adhesion-based high-throughput assay for the discovery of small-molecule regulators of the integrin CD11b/CD18. Park JY; Arnaout MA; Gupta V J Biomol Screen; 2007 Apr; 12(3):406-17. PubMed ID: 17438069 [TBL] [Abstract][Full Text] [Related]
12. Identity of the amino acid residues involved in C3bi binding to the I-domain supports a mosaic model to explain the broad ligand repertoire of integrin alpha M beta 2. Ustinov VA; Plow EF Biochemistry; 2005 Mar; 44(11):4357-64. PubMed ID: 15766265 [TBL] [Abstract][Full Text] [Related]
13. AlphaMbeta2 integrin modulator exerts antitumor activity in vivo. Suojanen J; Salo T; Sorsa T; Koivunen E Anticancer Res; 2007; 27(6B):3775-81. PubMed ID: 18225532 [TBL] [Abstract][Full Text] [Related]
14. Right on the spot. Chemokine triggering of integrin-mediated arrest of rolling leukocytes. Laudanna C; Alon R Thromb Haemost; 2006 Jan; 95(1):5-11. PubMed ID: 16543955 [TBL] [Abstract][Full Text] [Related]
15. Interfering with leukocyte integrin activation--a novel concept in the development of anti-inflammatory drugs. Hilden TJ; Nurmi SM; Fagerholm SC; Gahmberg CG Ann Med; 2006; 38(7):503-11. PubMed ID: 17101541 [TBL] [Abstract][Full Text] [Related]
16. Stabilization of the activated alphaMbeta2 integrin by a small molecule inhibits leukocyte migration and recruitment. Björklund M; Aitio O; Stefanidakis M; Suojanen J; Salo T; Sorsa T; Koivunen E Biochemistry; 2006 Mar; 45(9):2862-71. PubMed ID: 16503641 [TBL] [Abstract][Full Text] [Related]
17. Sequence gamma 377-395(P2), but not gamma 190-202(P1), is the binding site for the alpha MI-domain of integrin alpha M beta 2 in the gamma C-domain of fibrinogen. Ugarova TP; Lishko VK; Podolnikova NP; Okumura N; Merkulov SM; Yakubenko VP; Yee VC; Lord ST; Haas TA Biochemistry; 2003 Aug; 42(31):9365-73. PubMed ID: 12899623 [TBL] [Abstract][Full Text] [Related]